Talphera (TLPH) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free TLPH Stock Alerts $0.99 -0.04 (-3.88%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Talphera Stock Price Performance5 Day Performance-3.78%1 Month Performance-17.41%3 Month Performance+14.92% Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. TLPH Stock Chart for Wednesday, May, 8, 2024 TLPH Chart by TradingView Talphera Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.03$0.99-3.78%$1.05$0.9991,044 shs$16.84 million05/06/2024$1.02$1.03+0.98%$1.06$1.0336,448 shs$17.50 million05/03/2024$1.03$1.02-0.97%$1.04$0.9966,582 shs$17.33 million05/02/2024$1.00$1.03+3.00%$1.03$0.9918,349 shs$17.50 million05/01/2024$1.03$1.00-2.91%$1.06$1.0077,727 shs$16.97 million04/30/2024$0.99$1.03+4.04%$1.10$0.9743,970 shs$17.48 million Get the Latest News and Ratings for TLPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$1.05$0.99-5.71%$1.10$0.9841,439 shs$16.80 million04/26/2024$1.12$1.05-6.25%$1.08$1.0239,887 shs$17.82 million04/25/2024$0.97$1.12+15.46%$1.14$0.96258,792 shs$19.01 million04/24/2024$0.95$0.97+2.55%$1.05$0.9532,552 shs$16.46 million04/23/2024$0.93$0.95+1.71%$1.02$0.9320,477 shs$16.05 million04/22/2024$0.99$0.93-6.06%$0.99$0.9258,976 shs$15.78 million04/19/2024$1.03$0.99-3.88%$1.02$0.9577,151 shs$16.80 million04/18/2024$1.01$1.03+1.98%$1.05$1.0017,908 shs$17.48 million04/17/2024$1.02$1.01-0.98%$1.04$1.0146,334 shs$17.14 million04/16/2024$1.02$1.02$1.07$1.0067,409 shs$17.31 million04/15/2024$1.12$1.02-8.93%$1.14$1.00150,751 shs$17.31 million04/12/2024$1.14$1.13-0.88%$1.16$1.1230,747 shs$19.18 million04/11/2024$1.20$1.14-5.00%$1.19$1.0290,781 shs$19.35 million04/10/2024$1.20$1.20$1.22$1.1550,668 shs$20.36 million04/09/2024$1.17$1.20+2.56%$1.20$1.1369,261 shs$20.36 million04/08/2024$1.20$1.17-2.50%$1.24$1.1687,034 shs$19.86 million04/05/2024$1.10$1.20+9.09%$1.24$1.12162,268 shs$20.36 million04/04/2024$1.01$1.10+8.91%$1.13$1.03122,020 shs$18.67 million04/03/2024$0.98$1.01+2.85%$1.02$0.9848,082 shs$17.14 million04/02/2024$1.07$0.98-8.22%$1.09$0.9770,467 shs$16.67 million04/01/2024$1.03$1.07+3.88%$1.09$1.0322,316 shs$18.16 million03/29/2024$1.03$1.03$1.12$1.0181,350 shs$17.48 million03/28/2024$1.10$1.03-6.36%$1.12$1.0181,350 shs$17.48 million03/27/2024$1.12$1.10-1.79%$1.15$1.0879,510 shs$18.67 million03/26/2024$1.16$1.12-3.45%$1.16$1.0959,720 shs$19.01 million03/25/2024$1.14$1.16+1.75%$1.16$1.1243,831 shs$19.69 million03/22/2024$1.12$1.14+1.79%$1.14$1.0944,460 shs$19.35 million03/21/2024$1.09$1.12+2.75%$1.15$1.1031,965 shs$19.01 million03/20/2024$1.14$1.09-4.39%$1.19$1.0854,841 shs$18.50 million03/19/2024$1.15$1.14-0.87%$1.18$1.1355,999 shs$19.35 million03/18/2024$1.15$1.15$1.19$1.1256,715 shs$19.52 million03/15/2024$1.14$1.15+0.88%$1.18$1.1435,235 shs$19.51 million03/14/2024$1.17$1.14-2.56%$1.22$1.1278,993 shs$19.35 million03/13/2024$1.09$1.17+7.34%$1.18$1.0692,530 shs$19.86 millionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read03/12/2024$1.10$1.09-0.91%$1.21$1.0890,790 shs$18.50 million03/11/2024$1.13$1.10-2.22%$1.16$1.0941,627 shs$18.67 million03/08/2024$1.14$1.13-0.88%$1.18$1.0844,612 shs$19.07 million03/07/2024$1.27$1.14-10.63%$1.28$1.10165,408 shs$19.24 million03/06/2024$1.25$1.27+1.60%$1.31$1.2387,234 shs$21.53 million03/05/2024$1.30$1.25-3.85%$1.32$1.2246,923 shs$21.19 million03/04/2024$1.31$1.30-0.76%$1.31$1.2177,899 shs$22.04 million03/01/2024$1.36$1.31-3.68%$1.45$1.3158,417 shs$22.21 million02/29/2024$1.38$1.36-1.45%$1.40$1.2957,543 shs$23.05 million02/28/2024$1.37$1.38+0.73%$1.40$1.3545,935 shs$23.39 million02/27/2024$1.42$1.37-3.52%$1.44$1.35100,973 shs$23.22 million02/26/2024$1.47$1.42-3.40%$1.50$1.37135,503 shs$24.07 million02/23/2024$1.32$1.50+13.64%$1.50$1.28368,103 shs$25.43 million02/22/2024$1.22$1.32+8.20%$1.32$1.20109,372 shs$22.37 million02/21/2024$1.23$1.22-0.81%$1.28$1.2239,167 shs$20.68 million02/20/2024$1.25$1.23-1.60%$1.34$1.22113,631 shs$20.85 million02/19/2024$1.25$1.25$1.61$1.03855,100 shs$21.19 million02/16/2024$1.03$1.25+21.36%$1.61$1.03854,689 shs$21.19 million02/15/2024$1.03$1.03$1.10$0.99179,381 shs$17.46 million02/14/2024$1.03$1.03$1.09$1.0053,948 shs$17.46 million02/13/2024$1.10$1.03-6.36%$1.15$1.0035,971 shs$17.46 million02/12/2024$0.91$1.10+20.32%$1.16$0.88504,667 shs$18.65 million02/09/2024$0.86$0.91+6.30%$0.93$0.8437,182 shs$15.50 million02/08/2024$0.86$0.86-0.28%$0.93$0.8470,101 shs$14.58 million02/07/2024$0.90$0.86-3.77%$0.95$0.8650,753 shs$14.62 million02/06/2024$0.95$0.90-5.66%$0.94$0.88128,763 shs$15.19 million Related Companies: NeuroSense Therapeutics Stock Price Chart Indaptus Therapeutics Stock Price Chart Aytu BioPharma Stock Price Chart VBI Vaccines Stock Price Chart NeuroBo Pharmaceuticals Stock Price Chart Minerva Neurosciences Stock Price Chart Orgenesis Stock Price Chart Traws Pharma Stock Price Chart Cocrystal Pharma Stock Price Chart Avalo Therapeutics Stock Price Chart Receive TLPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TLPH) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorStock-Picking AI Predicts #1 Stock of 2024AltimetryThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.